Navigation Links
Lockheed Martin Invests in Smart Grid Research and Development at Penn State University
Date:2/26/2009

KING OF PRUSSIA, Pa., Feb. 26 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) has partnered with Penn State University to develop innovative solutions for the energy sector. As part of the corporation's commitment to tackling critical national energy challenges, Lockheed Martin will fund $400,000 of research and development projects at Penn State in 2009.

Leveraging a partnership spanning more than 30 years, this latest Lockheed Martin - Penn State collaboration will focus on Smart Grid technology. Specifically, the research will include advisory and control methods, predictive and diagnostic modeling and simulation, cyber security, and the development of a test bed for exploration, experimentation and validation of Advanced Meter Infrastructure and Smart Grid technologies.

"We believe that proven approaches to integrating and delivering complex, secure, defense systems can bring real benefit to energy partners as they look to implement secure scalable solutions, optimize critical resources, and manage risk," said Bill Graham, president of Lockheed Martin's Enterprise Integration Group. "We are pleased to be teaming with Penn State, an internationally-recognized leader in fundamental and applied energy research and development, on this nationally important issue."

"We're looking forward to combining the strengths of Penn State and Lockheed Martin to solve complex problems for the energy industry," said Dr. Tom Hughes, Director of the Energy Science & Power Systems division of Penn State's Applied Research Laboratory.

"This research will ensure that Smart Grid implementations are secure, protecting energy users' privacy and guaranteeing billing accuracy for utilities," said Patrick McDaniel, Associate Professor for Penn State's Computer Science and Engineering department.

Headquartered in Bethesda, Md., Lockheed Martin is a global security company that employs about 146,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. The corporation reported 2008 sales of $42.7 billion.

For additional information, visit our website: http://www.lockheedmartin.com


'/>"/>
SOURCE Lockheed Martin
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
2. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
3. Meredith Martin Addy Named One of Top 10 Illinois Super Lawyers for 2008
4. Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
5. Metabolex Names Zhao, Martin to Executive Posts
6. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
7. The PLSG Invests $115,000 in Innovention Technologies, LLC
8. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
9. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
10. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
11. JIC Invests in Three New Alternative Energy Projects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... of flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) ... portfolio of bioprocess media products engineered to radically streamline culture processes, minimize ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... ... 2016 , ... ACEA Biosciences, Inc. presented today updated efficacy ... for its lead drug candidate, AC0010, at the World Conference on Lung Cancer ... the safety, antitumor activity, and recommended phase II dosage of AC0010 in T790M-postitive ...
(Date:12/7/2016)... Capital Corp. ("Zenith" or the "Company") announces webcast details for ... Annual and Special Meeting. The Zenith Annual ... December 15, 2016 at Mount Royal ... Royal Gate SW, Calgary, Alberta , commencing ... information circular, containing the matters to be considered at the ...
Breaking Biology Technology:
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
(Date:12/6/2016)... , Dec. 6, 2016 Valencell , the ... it has seen a third consecutive year of triple ... technology in 2016 with a 360 percent increase in ... This increase was driven by sales of its wrist ... interest in its technology for hearables for fitness and ...
(Date:12/2/2016)... India , December 1, 2016 ... Authentication type (Fingerprint, Voice), Future Technology (Iris Recognition ... and Region - Global Forecast to 2021", published ... USD 442.7 Million in 2016, and is projected ... at a CAGR of 14.06%.      ...
Breaking Biology News(10 mins):